Dr. Reddy's Laboratories Ltd Common Stock vs Vanguard Short Term Corporate Bond ETF — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $13 (market cap $10.61B), while Vanguard Short Term Corporate Bond ETF trades at $77.4 (market cap $51.90B). The key difference: Vanguard Short Term Corporate Bond ETF is far larger — about 4.9× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Vanguard Short Term Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Vanguard Short Term Corporate Bond ETF for 54 Days on average.
| RDY | VCSH | |
|---|---|---|
Market Cap | $10.61B | $51.90B |
Volume | 3,738,869 | 12,465,005 |
Sector | Health | Fixed Income |
52-Week High | $15.38 | $80.20 |
52-Week Low | $11.38 | $77.03 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $10.51B | — |
Dividend Yield | 0.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VCSH trades at $77.32, down slightly by 0.05% today, with a bearish technical signal from moving averages and oscillators. The ETF maintains a competitive 4.5% dividend yield with consistent quarterly distributions of $0.30. Recent news highlights VCSH's low 0.03% expense ratio and short 2.7-year duration, positioning it as a high-quality short-term corporate bond option amid rising rate concerns.
Outlook remains cautious due to tight credit spreads and limited price appreciation potential. The ETF offers income stability but faces headwinds from potential spread widening and competition from broader bond ETFs. Risk-reward appears balanced for income-focused investors seeking short-duration corporate exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →